Evidence map›Paper›PMID 33623549›Full record

ArticleThe Pan African medical journal2020

Clinical presentation, case management and outcomes for the first 32 COVID-19 patients in Nigeria.

Abimbola Bowale, Akin Abayomi, Jide Idris, Sunday Omilabu, Ismail Abdus-Salam, Busayo Adebayo, Folarin Opawoye, Ore Finnih-Awokoya, Emmanuella Zamba, Hussein Abdur-Razzaq and 12 more

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 1 country.

Abimbola BowaleMainland Hospital, Yaba, Lagos, Nigeria.
Akin AbayomiLagos State Ministry of Health, Lagos, Nigeria.
Jide IdrisLagos State Ministry of Health, Lagos, Nigeria.
Sunday OmilabuCollege of Medicine University of Lagos, Lagos, Nigeria.
Ismail Abdus-SalamLagos State Ministry of Health, Lagos, Nigeria.
Busayo AdebayoLagos State University Teaching Hospital, Lagos, Nigeria.
Folarin OpawoyeLagos University Teaching Hospital, Lagos, Nigeria.
Ore Finnih-AwokoyaOffice of the Senior Special Assistant to the Governor, Lagos, Nigeria.
Emmanuella ZambaLagos State Ministry of Health, Lagos, Nigeria.
Hussein Abdur-RazzaqLagos State Ministry of Health, Lagos, Nigeria.
Olufemi ErinosoLagos State University Teaching Hospital, Lagos, Nigeria.
Tosin OnasanyaLagos State Primary Health Care Board, Lagos, Nigeria.
Patrick RamadanWorld Health Organization, Nigerian Office, Lagos, Nigeria.
Sam NyenyiWorld Health Organization, Nigerian Office, Lagos, Nigeria.
Evaristus AniakuNigerian Centre for Disease Control, Lagos, Nigeria.
Muhammad BalogunAfrican Field Epidemiology Network, Lagos, Nigeria.
Oyeladun OkunromadeNigerian Centre for Disease Control, Lagos, Nigeria.
Olusola AdejumoMainland Hospital, Yaba, Lagos, Nigeria.
Sunday AdesolaMainland Hospital, Yaba, Lagos, Nigeria.
Tope OgunniyanMainland Hospital, Yaba, Lagos, Nigeria.
Mobolanle BalogunCollege of Medicine University of Lagos, Lagos, Nigeria.
Akin OsibogunCollege of Medicine University of Lagos, Lagos, Nigeria.
University of Lagos · NGLagos State Health Service Commission · NGLagos State University Teaching Hospital · NGLagos University Teaching Hospital · NG

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionSuccess in curtailing the pandemic coronavirus disease (COVID-19) depends largely on a sound understanding of the epidemiologic and clinical profile of cases in a population as well as the case management approach. This study documents the presenting characteristics, treatment modalities and outcomes of the first 32 COVID-19 patients in Nigeria.

methodsThis retrospective study used medical records of the first 32 patients admitted and discharged from the Mainland Hospital, Lagos State, southwest Nigeria between February 27 and April 6, 2020. The outcomes of interest were death, promptness of admission process and duration of hospitalization.

resultsThe mean age of the patients was 38.1 years (SD: 15.5) and 66% were male. Three-quarters (75%) of the patients presented in moderately severe condition while 16% were asymptomatic. The most common presenting symptoms were fever (59%) and dry cough (44%). The mean time between a positive test result and admission was 1.63 days (SD: 1.31). Almost all (97%) the patients were treated with lopinavir-ritonavir with no recorded death. The median duration of hospital stay was 12 days (IQR: 9-13.5).

conclusionIn this preliminary analysis of the first COVID-19 cases in Nigeria, clinical presentation was mild to moderate with no mortality. Processes to improve promptness of admission and reduce hospital stay are required to enhance the response to COVID-19 in Nigeria.

Indexed as

AdolescentAdultCase ManagementChildChild, PreschoolCoughCOVID-19FemaleFeverHospitalizationHumansInfantLength of StayMaleMiddle AgedNigeriaclinical outcomesCOVID-19 presentationNigeriaretrospective study

Identifiers

PMID33623549
PMCPMC7875732
OpenAlexW3041949826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.